PsilodexMedication × psilocybin
Your list , 0 items
Medication class

Seizure medications and psilocybin.

31 records in this group. 3 have published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

31Records
3With human data

Also searched as anticonvulsant · antiepileptic · seizure medication · anti-seizure · epilepsy medication

01 What the evidence covers

Best evidence available per medication
1Open-label trial
2Case reports
Case reports or online surveys
28No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Brivaracetam · BriviactEvidence: No psilocybin data

    Partial-onset (focal) seizures

    Not studied with psilocybin; it can cause sleepiness and mood changes, so added sedation is possible. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Cannabidiol (prescription) · EpidiolexEvidence: No psilocybin data

    Seizures associated with Lennox-Gastaut syndrome; Seizures associated with Dravet syndrome

    It may slow how the body clears psilocybin, raising levels (not studied with psilocybin). Also, its label lists sleepiness, suicidal thoughts and liver enzyme rises.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Carbamazepine · Tegretol, Carbatrol, EquetroEvidence: No psilocybin data

    Partial seizures with complex symptoms; Generalized tonic-clonic seizures

    It may weaken psilocybin by speeding how the body clears psilocybin (untested). Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Cenobamate · XcopriEvidence: No psilocybin data

    Partial-onset (focal) seizures in adults

    Not studied with psilocybin; it causes sleepiness and dizziness. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Clobazam · Onfi, SympazanEvidence: No psilocybin data

    Seizures in Lennox-Gastaut syndrome (add-on)

    It adds sedation; untested with psilocybin (midazolam, the one studied, partly impaired memory of the session). Stopping it suddenly can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Clonazepam · KlonopinEvidence: No psilocybin data

    Seizures, including Lennox-Gastaut syndrome, akinetic, myoclonic and absence seizures; Panic disorder

    It adds sedation; untested with psilocybin (midazolam, the one studied, partly impaired memory of the session). Stopping it suddenly can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Diazepam · Valium, Diastat, Valtoco, LibervantEvidence: No psilocybin data

    Anxiety disorders; Alcohol withdrawal symptoms

    It adds sedation; untested with psilocybin (midazolam, the one studied, partly impaired memory of the session). Stopping it suddenly can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Eslicarbazepine · AptiomEvidence: No psilocybin data

    Partial-onset (focal) seizures (age 4 and older)

    It may lower psilocybin levels by speeding how the body clears psilocybin (untested). Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ethosuximide · ZarontinEvidence: No psilocybin data

    Absence (petit mal) seizures

    Not studied with psilocybin; no linking mechanism is described. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Felbamate · FelbatolEvidence: No psilocybin data

    Partial seizures in adults (severe, refractory epilepsy); Seizures of Lennox-Gastaut syndrome in children (add-on treatment)

    Not studied with psilocybin; its label warns of rare aplastic anemia and liver failure. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Fenfluramine · FinteplaEvidence: No psilocybin data

    Seizures associated with Dravet syndrome; Seizures associated with Lennox-Gastaut syndrome

    Not studied with psilocybin; it acts on the same serotonin receptors as psilocybin, so added or competing effects are possible.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Fosphenytoin · CerebyxEvidence: No psilocybin data

    Generalized tonic-clonic status epilepticus; Prevention and treatment of seizures during neurosurgery

    It may lower psilocybin levels by speeding how the body clears psilocybin (untested). Also, rapid infusion can cause severe low blood pressure.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Gabapentin · Neurontin, Gralise, HorizantEvidence: No psilocybin data

    Nerve pain after shingles (postherpetic neuralgia); Partial-onset seizures (add-on treatment)

    It may add drowsiness and does not act on serotonin (not studied with psilocybin). Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ganaxolone · ZtalmyEvidence: No psilocybin data

    Seizures of CDKL5 deficiency disorder (age 2 and older)

    Its effect on psilocybin is unknown; it causes sleepiness and sedation. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Lacosamide · Vimpat, Motpoly XREvidence: No psilocybin data

    Partial-onset (focal) seizures; Primary generalized tonic-clonic seizures (add-on therapy)

    Not studied with psilocybin; no linking mechanism is described. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Lamotrigine · LamictalEvidence: Case reports

    Partial-onset (focal) seizures; Primary generalized tonic-clonic seizures

    In 34 reports with classic psychedelics like psilocybin, none described a seizure; most noted no change. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Levetiracetam · KeppraEvidence: No psilocybin data

    Partial-onset seizures; Myoclonic seizures in juvenile myoclonic epilepsy (add-on)

    Not studied with psilocybin. Also, it can cause sleepiness, irritability and mood changes, and sometimes psychotic symptoms or suicidal thoughts.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Midazolam · Nayzilam, SeizalamEvidence: Open-label trial

    Sedation, anxiety relief, and amnesia before or during surgery and medical procedures; Starting general anesthesia

    In a small study, midazolam with psilocybin left the experience conscious but partly impaired memory of it; it also adds sedation.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Oxcarbazepine · Trileptal, Oxtellar XREvidence: No psilocybin data

    Partial-onset (focal) seizures

    Not studied with psilocybin; it can lower blood sodium, so heavy water drinking during a session could lower it further.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Perampanel · FycompaEvidence: No psilocybin data

    Partial-onset seizures (ages 4 and older); Primary generalized tonic-clonic seizures (add-on, ages 12 and older)

    Not studied with psilocybin, and any effect on how the body clears psilocybin is untested. Also, its boxed warning covers serious psychiatric reactions, including aggression.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • PhenobarbitalEvidence: No psilocybin data

    Seizures in newborns (neonatal seizures; injectable form)

    Not studied with psilocybin; it speeds the breakdown of drugs, so lower psilocybin levels are possible. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Phenytoin · DilantinEvidence: No psilocybin data

    Seizures (tonic-clonic and complex partial/focal); Seizures during or after brain surgery (neurosurgery)

    Not studied with psilocybin; it strongly speeds drug breakdown, so lower psilocybin levels are possible. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Pregabalin · LyricaEvidence: No psilocybin data

    Diabetic nerve pain (diabetic peripheral neuropathy); Nerve pain after shingles (postherpetic neuralgia)

    Its sleepiness may add to psilocybin's effects. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Primidone · MysolineEvidence: No psilocybin data

    Epilepsy (grand mal, psychomotor and focal seizures)

    Not studied with psilocybin; it speeds drug breakdown, so weaker or shorter psilocybin effects are possible. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Rufinamide · BanzelEvidence: No psilocybin data

    Seizures of Lennox-Gastaut syndrome (add-on treatment, age 1 and older)

    Not studied with psilocybin; it weakly speeds drug breakdown, so slightly lower psilocybin levels are possible. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Stiripentol · DiacomitEvidence: No psilocybin data

    Seizures of Dravet syndrome (taken with clobazam, age 6 months and older)

    Not studied with psilocybin; it blocks an enzyme that clears psilocybin, so higher levels are possible. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Tiagabine · GabitrilEvidence: No psilocybin data

    Partial (focal) seizures, as add-on therapy (age 12+)

    Not studied with psilocybin; it may add to sedation. Also, it can provoke seizures, even in people without epilepsy.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Topiramate · Topamax, Trokendi XR, Qudexy XREvidence: No psilocybin data

    Partial-onset seizures; Generalized tonic-clonic seizures

    No direct interaction with psilocybin is expected. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Valproate · Depakene, DepakoteEvidence: Case reports

    Complex partial (focal) seizures; Absence seizures (simple and complex), alone or with other seizure types

    In one case, psilocybin mushrooms with valproate, phenelzine and other drugs had no noticeable effect. It may also slow how the body clears psilocybin.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Vigabatrin · Sabril, Vigadrone, VigafydeEvidence: No psilocybin data

    Refractory complex partial (focal) seizures (add-on, age 2 and older); Infantile spasms (age 1 month to 2 years)

    Not studied with psilocybin, and any effect on it is unknown. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Zonisamide · ZonegranEvidence: No psilocybin data

    Partial (focal) seizures in adults, as add-on therapy

    No known direct interaction with psilocybin; it can reduce sweating and cause overheating. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
31Withdrawal or rebound if stopped abruptly
29Sedating or CNS depressant
26Psychiatric reactions
12Speeds up drug metabolism
8Liver injury
3Dehydration or electrolyte risk
3Lowers seizure threshold or carries seizure risk
2Lowers blood pressure or causes orthostasis
2UGT inhibition (theoretical effect on psilocin levels)
1Anticholinergic
1QT-prolonging
1Raises blood pressure or heart rate
1Serotonergic

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group.

Rule 2.2(A)(9): a facilitator must tell prospective participants in writing that anyone taking a psychotropic medication identified as a risk factor on the safety screen must meet one of the 2.2(A)(7) conditions. 15 of the 31 medications in this group are psychotropic; the rule applies when one is identified as a risk factor on a participant's screen.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
6Thomann J, Kolaczynska KE, Stoeckmann OV, et al. In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin. Front Pharmacol 2024;15:1391689.
5Halman A, Kong G, Sarris J, Perkins D. Drug–drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol 2024;38(1):3–18.
5Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 2022;239(6):1945–1976.
4Nicholas CR, Banks MI, Lennertz RC, et al. Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience. Transl Psychiatry 2024;14:372.
1Barnett BS, Koons CJ, Van den Eynde V, et al. Hypertensive emergency secondary to combining psilocybin mushrooms, extended release dextroamphetamine-amphetamine, and tranylcypromine. J Psychoactive Drugs 2024;57(3):297–303.
1Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. J Psychopharmacol 2008;22(6):603–620.
1Nayak SM, Gukasyan N, Barrett FS, et al. Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures. Pharmacopsychiatry 2021.
1Sutherland MH, Nicholas CR, Lennertz RC, et al. Electrophysiological effects of psilocybin co-administered with midazolam. Transl Psychiatry 2026;16.
1Tap SC, Thomas K, Páleníček T, et al. Concomitant use of antidepressants and classic psychedelics: a scoping review. J Psychopharmacol 2025.

Related classes

Records reviewed 2026-10-03 to 2026-10-25. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25